Balancing Opioid Prescriptions After Urologic Surgery: New Study Links Extremes to Higher Refill Rates
In a finding that challenges the one-size-fits-all approach to post-surgical pain, researchers reported that both underprescribing and overprescribing opioids after urologic procedures significantly increased the likelihood of patients needing a refill. The research, unveiled at a medical meeting in Washington, highlights a delicate balancing act: giving too few pills leaves patients in pain and seeking more, while loading them up with large quantities of opioids may paradoxically lead to higher refill requests—potentially due to faster tolerance, mismatched expectations, or unused pills being diverted. For the millions of Americans undergoing kidney stone removal, prostate surgery, or other common urologic operations each year, the findings could eventually reshape discharge conversations and prescribing habits, though the full study details remain limited as the work has not yet been published in a peer-reviewed journal.
Background: The Opioid Tightrope After Surgery
Surgical care has long been a major gateway to opioid use, and urology is no exception. Procedures such as nephrectomy, transurethral resection of the prostate, and ureteroscopy routinely cause moderate to severe acute pain that requires medication management. For years, the prevailing wisdom was to prescribe generously to prevent suffering, partly driven by patient satisfaction surveys that tied pain control to quality scores. This often resulted in patients receiving 30 or more opioid tablets for a procedure that might cause only a few days of serious discomfort.
In response to the opioid epidemic, guidelines from groups like the American Urological Association began steering clinicians toward more restrained prescribing—often recommending fewer pills or even non-opioid alternatives. However, data on exactly what that “right” amount looks like have been scarce. Previous studies in general surgery and orthopedics had already hinted that overprescribing fails to improve satisfaction and may increase long-term opioid use, but the relationship has been less clear in urologic surgery, where pain trajectories and patient demographics differ. The concept that too little medication could also drive refills—and potentially signal undertreated pain—adds an important layer to the conversation.
The Evidence: What the Study Found
According to a report from the conference, the study analyzed opioid prescribing patterns at hospital discharge following a range of urologic surgeries. The researchers tracked whether patients requested an additional opioid prescription—a refill—within a certain period after the initial prescription was exhausted. The headline result was that both the lowest and the highest amounts of opioids dispensed at discharge were associated with a higher probability of refill, forming a U-shaped risk curve.
The lead author’s name, institutional affiliation, journal, and year were not disclosed in the preliminary report reviewed for this article. The study type appears to be a retrospective analysis, but the exact sample size, specific urologic surgeries included, age range of participants, and follow-up duration were not provided. Crucially, the reported data did not include concrete numbers—such as the percentage increase in refill risk, odds ratios, or confidence intervals—that would allow a robust assessment of effect size. The research was presented at a medical conference in Washington, but the meeting’s name and date were not specified in the available summary. As a conference abstract, the work has likely not undergone full peer review, and details may change before final publication.
Despite these gaps, the core finding—that there appears to be a “sweet spot” of opioid prescribing that minimizes refills—is consistent with broader literature. For example, a 2017 study by Howard et al. in JAMA Surgery found that reducing prescription size for certain procedures did not increase refill requests. The new study extends that idea by showing that underprescribing may be just as problematic as overprescribing, but the absence of specific cutoffs or dosing thresholds limits immediate clinical application.
What This Means for You
If you or a loved one is scheduled for urologic surgery, this research underscores the importance of a personalized pain management plan. Rather than accepting a standard prescription without question, patients should discuss the expected duration and intensity of pain, their personal history with pain medications, and the possibility of starting with a smaller quantity of opioids combined with non-drug strategies such as ice packs, anti-inflammatory medications, and nerve blocks where appropriate. The goal is to have enough medication to manage acute pain—typically the first 48 to 72 hours—while minimizing leftover pills that could be misused.
It’s also critical to recognize that requesting a refill is not a failure. Tracking refill rates is a research metric, not a moral judgment. If pain persists beyond what was anticipated, contacting your surgeon’s office is the correct step. However, the study’s signal suggests that when large initial prescriptions drive refill requests, something else may be at play—possibly the development of opioid tolerance or unrealistic expectations set by having too many pills on hand. In practical terms, ask your doctor: “How many pills do most patients like me actually take, and what’s the plan if I need more?”
Expert Perspective
No named expert commentary accompanied the news brief, but the limitations of this type of early-stage research invite caution. Conference presentations often lack the methodological detail and peer scrutiny of published papers. It is possible that the association between extreme prescribing and refills is confounded by patient factors—those in more pain might both receive and demand more medication, while those who receive very little might have had a complication or a pre-existing chronic pain condition. Until the full analysis is available, clinicians are likely to view these results as hypothesis-generating rather than practice-changing. The next steps should include a multivariable analysis adjusting for patient characteristics, pain scores, and surgical complexity, as well as a clearly defined “appropriate” prescription range in morphine milligram equivalents.
Frequently Asked Questions
Q: What counts as “too much” or “too little” opioid after urologic surgery?
In the context of this study, the thresholds were not publicly disclosed. Generally, for many urologic procedures, a prescription of 10 to 15 tablets of an immediate-release opioid like oxycodone 5 mg is considered moderate. Quantities above 20 to 30 tablets may be viewed as excessive, while fewer than 5 tablets could be insufficient for acute pain. These numbers vary by surgery type and patient characteristics.
Q: Why would overprescribing lead to more refill requests?
The study did not explain the mechanism, but researchers have proposed several possibilities. Patients with large numbers of pills might take them more frequently, accelerating tolerance and leading to increased pain sensitivity. A bigger prescription may also signal to the patient that pain will be severe, shaping expectations. Additionally, if patients finish a large supply earlier than instructed, it could raise red flags about misuse or diversion, prompting the patient to request more.
Q: Does this mean I should try to get a medium-sized prescription?
Not exactly. The ideal approach is not about hitting a magic number; it’s about matching the prescription to your procedure, pain history, and personal response. Speak openly with your surgeon about your concerns regarding both pain control and opioid exposure. Some patients may do well with a non-opioid plan and a small rescue prescription. Others with a history of severe acute pain may need a slightly larger supply with close follow-up.
Q: How do surgeons decide how many pills to prescribe?
Traditionally, prescribing habits have been shaped by habit, peer practice, and fear of late-night calls from patients in pain. In recent years, many institutions have adopted procedure-specific guidelines based on actual patient usage data—often gathered by asking patients how many pills they consumed post-surgery. This study’s findings, once published in full, could help refine those guidelines by directly linking prescription size to refill probability.
Q: Is refill rate a reliable measure of pain management quality?
Refill rate is a convenient metric because it is easily captured in pharmacy databases, but it has limitations. A refill can reflect uncontrolled pain, but it can also indicate a patient who lost medication or developed a complication requiring more analgesia. It does not capture patients who suffered in silence or those who diverted medication. Researchers often combine refill data with patient-reported pain scores and functional outcomes for a fuller picture.
Sources
- MedPage Today (2025). Too Much or Too Little Opioid Pain Relief May Drive Refills After Urologic Surgery. Conference reporting, Washington. Note: Full author list, institution, and study specifics were not available in the initial report.
